小摩力荐2025年医疗科技三大金股：波士顿科学(BSX.US) 、直觉外科 (ISRG.US) 与银休特 (PODD.US)

智通财经2025-01-06

智通财经APP获悉，摩根大通在其新年报告中将波士顿科学 (BSX.US) 和直觉外科公司 (ISRG.US) 选为医疗科技领域的首选大盘股，并重申对胰岛素泵制造商银休特 (PODD.US) 在中小型医疗科技领域的青睐。该行分析师罗比·马库斯 (Robbie Marcus) 表示，2025 年医疗科技行业仍将保持高度吸引力，主要得益于潜在的估计和历史倍数修正，以及强劲的现金流预期。马库斯强调，该行业...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2501055754?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-06 15:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501055754","market":"sh","top_or_hot":-1,"title":"小摩力荐2025年医疗科技三大金股：波士顿科学(BSX.US) 、直觉外科 (ISRG.US) 与银休特 (PODD.US)","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，摩根大通在其新年报告中将波士顿科学 (BSX.US) 和直觉外科公司 (ISRG.US) 选为医疗科技领域的首选大盘股，并重申对胰岛素泵制造商银休特 (PODD.US) 在中小型医疗科技领域的青睐。该行分析师罗比·马库斯 (Robbie Marcus) 表示，2025 年医疗科技行业仍将保持高度吸引力，主要得益于潜在的估计和历史倍数修正，以及强劲的现金流预期。马库斯强调，该行业...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1233700.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>小摩力荐2025年医疗科技三大金股：波士顿科学(BSX.US) 、直觉外科 (ISRG.US) 与银休特 (PODD.US)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n小摩力荐2025年医疗科技三大金股：波士顿科学(BSX.US) 、直觉外科 (ISRG.US) 与银休特 (PODD.US)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-06 15:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1233700.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，摩根大通在其新年报告中将波士顿科学 (BSX.US) 和直觉外科公司 (ISRG.US) 选为医疗科技领域的首选大盘股，并重申对胰岛素泵制造商银休特 (PODD.US) 在中小型医疗科技领域的青睐。该行分析师罗比·马库斯 (Robbie Marcus) 表示，2025 年医疗科技行业仍将保持高度吸引力，主要得益于潜在的估计和历史倍数修正，以及强劲的现金流预期。马库斯强调，该行业...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1233700.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1233700.html","article_id":"2501055754","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501055754","pubTimestamp":1736147182,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，摩根大通在其新年报告中将波士顿科学  和直觉外科公司  选为医疗科技领域的首选大盘股，并重申对胰岛素泵制造商银休特  在中小型医疗科技领域的青睐。对于波士顿科学，马库斯预计该公司将继续保持强劲的增长势头，主要得益于心脏设备利润率的提高和 PFA系统及 WATCHMAN 的发展。在直觉外科公司方面，马库斯的看涨观点主要受到该公司新款 da Vinci 5 机器人手术系统的支持。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159891":"医疗","BK4082":"医疗保健设备","LU0215105999.USD":"SCHRODER ISF GLOBAL EQUITY \"A\" ACC","LU1032466523.USD":"高盛全球多资产收益组合Acc","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","BK4504":"桥水持仓","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","LU0122379950.USD":"贝莱德世界健康科学A2","BK4588":"碎股","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","LU0251132253.USD":"FIDELITY FUNDS  GLOBAL THEMATIC OPPORTUNITIES \"A\" (USD) ACC","LU2506951875.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","BSX":"波士顿科学","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU0211326839.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) INC","BK4551":"寇图资本持仓","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU1496350171.SGD":"FRANKLIN DIVERSIFIED BALANCED \"A\" (SGDHDG) ACC","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU0683600562.USD":"AB SELECT US EQUITY \"A\" (USD) ACC","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","BK4581":"高盛持仓","LU1923623000.USD":"Natixis Thematics AI & Robotics Fund R/A USD","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","PODD":"银休特","LU0787776722.HKD":"AB SELECT US EQUITY PORTFOLIO \"A\" (HKD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU0971096721.USD":"富达环球金融服务 A","BK4585":"ETF&股票定投概念","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","ISRG":"直觉外科公司","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","IE00BHPRN162.USD":"BNY MELLON BLOCKCHAIN INNOVATION \"B\" (USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0079474960.USD":"联博美国增长基金A","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC"},"translate_title":"JPMorgan strongly recommends three major medical technology gold stocks in 2025: Boston Scientific (BSX.US), Intuitive Surgery (ISRG.US) and Silver Huit (PODD.US)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"BSX":1,"ISRG":1,"PODD":1},"content_text":"智通财经APP获悉，摩根大通在其新年报告中将波士顿科学 (BSX.US) 和直觉外科公司 (ISRG.US) 选为医疗科技领域的首选大盘股，并重申对胰岛素泵制造商银休特 (PODD.US) 在中小型医疗科技领域的青睐。该行分析师罗比·马库斯 (Robbie Marcus) 表示，2025 年医疗科技行业仍将保持高度吸引力，主要得益于潜在的估计和历史倍数修正，以及强劲的现金流预期。马库斯强调，该行业的回报将主要依赖于个股表现，因此 2025 年将是选股的重要一年。对于波士顿科学，马库斯预计该公司将继续保持强劲的增长势头，主要得益于心脏设备利润率的提高和 PFA(脉冲场消融)系统及 WATCHMAN 的发展。他指出，PFA 将提高毛利率，而 WATCHMAN 的销售可能会加速，且定价基本保持平稳，这将显著改善自由现金流的转换率。在直觉外科公司方面，马库斯的看涨观点主要受到该公司新款 da Vinci 5 机器人手术系统的支持。他认为，随着管理层全面推出该系统并开始瞄准以旧换新账户，公司将迎来更大的增长空间。尽管市场对 da Vinci 5 和整体业务的期望很高，但马库斯看到了许多积极的推动因素，这些因素将推动 da Vinci 5 在 2025 年再次实现强劲表现。对于银休特，马库斯称其为“医疗科技领域最优质的品牌之一”，并预计该公司在 2025 年及以后将继续实现强劲的营收增长、利润率提高和显著的自由现金流产生。他指出，与过去几年不同，投资者现在更加关注盈利能力和每股收益的增长，而银休特在这两方面的表现预计将大幅提高，并继续以健康的速度增长。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2501055754","isCrawlerRequest":true}